SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-18-000006
Filing Date
2018-03-09
Accepted
2018-03-09 16:28:42
Documents
2
Period of Report
2018-03-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20180309x8k.htm 8-K 38586
2 EX-3.1 bpmx-20180309ex31247c79c.htm EX-3.1 22783
  Complete submission text file 0001504167-18-000006.txt   62588
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 18680440
SIC: 2834 Pharmaceutical Preparations